This market research report presents a detailed segmentation of the global acne drugs 2016- 2020 market by drug class (antibiotics, anti-inflammatory drugs, antimicrobial, combination medications, hormonal agents, oral retinoid, and topical retinoid), by route of administration (topical, and oral), and by type (prescription and OTC).
It outlines the market shares for key regions such as the Americas, APAC, and EMEA. The key vendors analyzed in this report are Allergan, Galderma, Stiefel, and Valeant.
Market outlook of acne drugs
Technavios market research analyst predicts the global acne drugs market to grow steadily at a CAGR of approximately 3% during the forecast period. The occurrence of acne due to lifestyle changes is the primary driver for the market. Sedentary lifestyle and unhealthy food habits lead to hormonal problems, which trigger the development of acne. Lack of sleep, emotional and work-related stress, smoking, drug abuse, and alcohol consumption are major triggers for the occurrence of acne among teenagers and adults.
The rise in disposable income has encouraged consumers, especially the middle-class income group, to spend more on personal care products. The rising awareness of acne and the current and upcoming treatments is expected to drive the acne drugs market through the forecast period. Women particularly, play a crucial role in this market as the demand generated by them influences the market growth considerably.
- 6 Yummy Foods That Are Causing Your Adult Acne
- How To Fight Adult Acne
- Acne Home Remedies
- Acne No More Review
- Acne Drugs Global Market for 2016-2020
- 7 Foods That May Trigger Your Acne
- How To Get Rid of Acne Forever
Segmentation by drug class and analysis of the acne drugs market:
Acne medication depends on the skin type and the severity of the condition. For instance, oral retinoid agents are considered as the appropriate treatment for severe acne. These drugs help prevent excessive oil production, bacterial acne growth, and inflammation.
Segmentation by method of administration and analysis of the acne drugs market
The topical drugs segment dominated the market during 2015, accounting for a market share of around 54%. Ease of application, low systemic side-effects, and easy availability of these products are the primary drivers for the growth of this segment.
Segmentation by type and analysis of the acne drugs market
Prescription drugs dominated the market during 2015 due to the increased awareness about acne and the treatments options, especially in the developed countries. For instance, Epiduo, Benzaclin, and Duac are some of the popular acne prescription drugs available in the market.
Segmentation by geography and analysis of the acne drugs 2016-2020 market
The Americas accounted for around 90% of the market share during 2015 but is expected to witness a decline in sales during the forecast period. Lifestyle changes, increase in awareness programs about acne, and availability of acne treatment options are the primary drivers for market growth in this region.
Competitive landscape and key acne drug vendors
The global acne drugs market is dominated by key vendors. The availability of OTC drugs and the preference for alternative therapies for treating acne has been restricting the sales of branded acne products. Vendors in this market are anticipated to invest heavily on R&D during the forecast period.
The leading vendors in the market are for acne drugs 2016 are:
The other prominent acne drugs vendors in the market include: AndroScience,Anterios, Aqua Pharmaceuticals, Astellas, Bayer HealthCare, BioPharmX, Celtaxsys, Cipher Pharmaceuticals, COSMO Pharmaceuticals, Dermira, Elorac, F.Hoffmann-La Roche, Foamix, GlaxoSmithKline, Guthy-Renker, Helix BioMedix, Hygeia Therapeutics, Johnson & Johnson, Media, Mylan, Novan, Oculus Innovative Sciences, Paratek Pharmaceuticals, Photocure, Promius Pharma, Ranbaxy, Reckitt Benckiser, Skinvisible Pharmaceuticals, Teva, Versapharm, and XBiotech.